Adient Analyst Price Targets - Benzinga

Adient PLC

ADNTNYSE

Trade with Public

Trade with Public

$18.00

-0.18-1.02%

마지막 업데이트: Oct 16, 2:59 PM

$18.19

0.010.06%

개요 뉴스 실적 전망 이벤트목표가재무 심리 지분 현황 비교 옵션 주식 보고서

Adient Analyst Price Targets - Benzinga

Adient Analyst Price Targets

Wall Street analyst price targets and consensus rating for Adient (ADNT).

Price Target Range — 13 Quarters

Analyst Consensus — 9 Analysts

7Buy

1Hold

1Sell

Consensus RatingBuy# Analysts9Avg. Consensus PT$25Upside to Avg. PT+39.8%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 9, 2026	Barclays	Dan Levy	PT Cut	Equal-Weight	$25→$22
Oct 7, 2026	UBS	Joseph Spak	PT Cut	Buy	$29→$23
Sep 15, 2026	JP Morgan	Rajat Gupta	Upgrade	Neutral→Overweight	$28→$25
Aug 18, 2026	Morgan Stanley	Andrew Percoco	PT Cut	Equal-Weight	$22→$21
Aug 11, 2026	Citigroup	Michael Ward	PT Cut	Buy	$33→$29
Aug 10, 2026	JP Morgan	Rajat Gupta	PT Raise	Neutral	$26→$28
Aug 10, 2026	Barclays	Dan Levy	PT Cut	Equal-Weight	$29→$25
Aug 6, 2026	UBS	Joseph Spak	PT Cut	Buy	$34→$29
Jul 20, 2026	Stifel	Nathan Janes	PT Cut	Buy	$28→$26
Jul 9, 2026	UBS	Joseph Spak	PT Raise	Buy	$33→$34
Jul 6, 2026	Deutsche Bank	Edison Yu	PT Cut	Buy	$31→$29
Jun 25, 2026	Wells Fargo	Colin Langan	PT Raise	Overweight	$28→$32
May 11, 2026	Barclays	Dan Levy	PT Raise	Equal-Weight	$26→$29
May 7, 2026	UBS	Joseph Spak	PT Raise	Buy	$32→$33
Apr 23, 2026	JP Morgan	Ryan Brinkman	PT Cut	Neutral	$28→$26
Apr 15, 2026	Citigroup	Michael Ward	Upgrade	Neutral→Buy	$30→$33
Apr 14, 2026	Stifel	Nathan Janes	PT Cut	Buy	$30→$26
Mar 31, 2026	Wells Fargo	Colin Langan	PT Cut	Overweight	$29→$28
Mar 30, 2026	Barclays	Dan Levy	PT Cut	Equal-Weight	$27→$26
Feb 9, 2026	Citigroup	Michael Ward	PT Raise	Neutral	$23→$30

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Barclays Maintains Equal-Weight on Adient, Lowers Price Target to $22

Barclays analyst Dan Levy maintains Adient (NYSE:ADNT) with a Equal-Weight and lowers the price target from $25 to $22.

Benzinga Newsdesk

PRO
UBS Maintains Buy on Adient, Lowers Price Target to $23

UBS analyst Joseph Spak maintains Adient (NYSE:ADNT) with a Buy and lowers the price target from $29 to $23.

Benzinga Newsdesk

PRO
JP Morgan Upgrades Adient to Overweight, Lowers Price Target to $25

JP Morgan analyst Rajat Gupta upgrades Adient (NYSE:ADNT) from Neutral to Overweight and lowers the price target from $28 to $25.

Benzinga Newsdesk

PRO
Morgan Stanley Maintains Equal-Weight on Adient, Lowers Price Target to $21

Morgan Stanley analyst Andrew Percoco maintains Adient (NYSE:ADNT) with a Equal-Weight and lowers the price target from $22 to $21.

Benzinga Newsdesk

PRO
Citigroup Maintains Buy on Adient, Lowers Price Target to $29

Citigroup analyst Michael Ward maintains Adient (NYSE:ADNT) with a Buy and lowers the price target from $33 to $29.

Benzinga Newsdesk

PRO
JP Morgan Maintains Neutral on Adient, Raises Price Target to $28

JP Morgan analyst Rajat Gupta maintains Adient (NYSE:ADNT) with a Neutral and raises the price target from $26 to $28.

Benzinga Newsdesk